Indica Labs specializes in advanced digital pathology solutions, primarily through its HALO software suite, which integrates artificial intelligence (AI) to enhance image analysis and diagnostic processes. The HALO AP Dx platform is FDA-cleared for primary diagnosis, enabling pathologists to conduct case-centric evaluations efficiently. This platform supports various workflows in anatomic pathology, including remote working capabilities, which are essential for modern diagnostic practices. Additionally, the HALO Clinical AI solutions offer tools for detecting and grading specific cancers, such as prostate adenocarcinoma and non-small cell lung cancer (NSCLC), while also quantifying important biomarkers in breast cancer, thereby streamlining the diagnostic process.

The company also provides collaborative image management through HALO Link, which facilitates communication and data sharing among pathologists. Indica Labs' AI-powered services extend to pharmaceutical applications, enhancing research and discovery efforts in the life sciences. Their technology is designed to improve the accuracy and reproducibility of diagnoses, making it a valuable asset in both clinical and research settings. With a focus on user-friendly interfaces and comprehensive support, Indica Labs aims to transform pathology workflows, making them more efficient and effective for healthcare professionals worldwide.

United States

Indica Labs is a digital pathology company that specializes in advanced software solutions for medical imaging and analysis in the field of healthcare technology.

Indica Labs

Company Details